Wockhardt Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Habil Khorakiwala says: “We have earlier signed an agreement on a profit-sharing basis for contract manufacturing with Serum Institute to make vaccines in our UK facility. This is a long 15-year agreement and we have earmarked capacity for 150 million doses for them. We are also in discussion with a global vaccine company for contract manufacturing opportunities.”

The Indo-Islamic Cultural Foundation (IICF), working for the construction of the mosque in Dhannipur, has said that there is no need to compete with the construction of Shri Ram temple in Ayodhya where the mosque is concerned.Reacting to some ...

The design of a mosque to be built on a five-acre land in Ayodhya's Dhannipur village awarded by the Supreme Court in the Ram Janmabhoomi-Babri Masjid verdict has been changed.

Investegate announcements from Rurelec PLC, 2021 Audited Results

This is a path breaking therapy where growth factors derived from the patient’s own platelets are further purified and used as a cellular growth factor giving consistent quality and quantity. This advanced therapy has a high scope of preventing diabetic foot amputation and the clinical studies have shown resounding success.